Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Update on pharmacological strategies for stroke: prevention, acute intervention and regeneration.

Legos JJ, Barone FC.

Curr Opin Investig Drugs. 2003 Jul;4(7):847-58. Review.

PMID:
14619407
2.

Non-surgical management of spinal cord injury.

Legos JJ, Gopez JJ, Young WF.

Expert Opin Investig Drugs. 2002 Apr;11(4):469-82. Review. Erratum in: Expert Opin Investig Drugs 2002 Nov;11(11):1693.

PMID:
11922856
3.

Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.

Candelario-Jalil E.

Curr Opin Investig Drugs. 2009 Jul;10(7):644-54. Review.

PMID:
19579170
4.

Therapeutic advances in acute ischaemic stroke.

Bhalla A, Rudd AG.

Int J Clin Pract. 1999 Jun;53(4):295-300. Review.

PMID:
10563075
5.

Ischemic stroke intervention requires mixed cellular protection of the penumbra.

Barone FC.

Curr Opin Investig Drugs. 2009 Mar;10(3):220-3. Review.

PMID:
19333878
6.

Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics.

Chen SD, Lee JM, Yang DI, Nassief A, Hsu CY.

Am J Cardiovasc Drugs. 2002;2(5):303-13. Review.

PMID:
14727960
7.

Emerging drugs for spinal cord injury.

Baptiste DC, Fehlings MG.

Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80. doi: 10.1517/14728214.13.1.63 . Review.

PMID:
18321149
8.

Pharmacological interventions for stroke: failures and future.

Legos JJ, Tuma RF, Barone FC.

Expert Opin Investig Drugs. 2002 May;11(5):603-14. Review.

PMID:
11996643
9.

New perspectives on developing acute stroke therapy.

Fisher M, Ratan R.

Ann Neurol. 2003 Jan;53(1):10-20. Review.

PMID:
12509843
10.

The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.

Tatlisumak T, Strbian D, Abo Ramadan U, Li F.

Curr Vasc Pharmacol. 2004 Oct;2(4):343-55. Review.

PMID:
15320814
11.

Treatments for stroke.

Beresford IJ, Parsons AA, Hunter AJ.

Expert Opin Emerg Drugs. 2003 May;8(1):103-22. Review.

PMID:
14610916
12.

Drugs for stroke recovery: the example of amphetamines.

Martinsson L, Eksborg S.

Drugs Aging. 2004;21(2):67-79. Review.

PMID:
14960125
13.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
14.

Intervention strategies for neonatal hypoxic-ischemic cerebral injury.

Perlman JM.

Clin Ther. 2006 Sep;28(9):1353-65. Review.

PMID:
17062309
15.

Recommendations and treatment strategies for the management of acute ischemic stroke.

Segura T, Calleja S, Jordan J.

Expert Opin Pharmacother. 2008 May;9(7):1071-85. doi: 10.1517/14656566.9.7.1071. Review.

PMID:
18422467
16.

Target brain: neuroprotection and neurorestoration in ischemic stroke.

Saver JL.

Rev Neurol Dis. 2010;7 Suppl 1:S14-21. Review.

PMID:
20410866
17.

Neuroprotection in acute stroke.

Chua HC, Ng PY.

Ann Acad Med Singapore. 2001 Mar;30(2):134-42. Review.

PMID:
11379410
18.

Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits.

d'Esterre CD, Lee TY.

Ann N Y Acad Sci. 2010 Oct;1207:71-5. doi: 10.1111/j.1749-6632.2010.05801.x. Review.

PMID:
20955428
19.

Advances in ischemic stroke treatment: neuroprotective and combination therapies.

Lapchak PA, Araujo DM.

Expert Opin Emerg Drugs. 2007 Mar;12(1):97-112. Review.

PMID:
17355216
20.

Acute ischemic stroke management: administration of thrombolytics, neuroprotectants, and general principles of medical management.

Khaja AM.

Neurol Clin. 2008 Nov;26(4):943-61, viii. doi: 10.1016/j.ncl.2008.07.002. Review.

PMID:
19026898

Supplemental Content

Support Center